@article{Hamidi_Alamdari_D-2021_39370,
title = {Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3},
author = {Hamidi Alamdari, D. and Hafizi Lotfabadi, S. and Agheli-Rad, M. and Barazandeh Ahmadabadi, F. and Morovatdar, N. and Bagheri-Moghaddam, A. and Safari, H. and Mozdourian, M. and Peivandi, Y.A. and Ali-Zeraati, A. and Sedaghat, A. and Poursadegh, F. and Tavousi, S. and Vojouhi, S. and Amini, S. and Amini, M. and Majid-Hosseini, S. and Tavanaee-Sani, A. and Ghiabi, A. and Nabavi-Mahalli, S. and Rajabi, O. and Koliakos, G.},
month = {jul},
year = {2021},
abstract = {Background:There is no pharmacological intervention on the treatment of hypoxemia and respiratory distress in COVID-19 patients.},
pages = {190-198},
volume = {73},
issue = {3},
journal = {Revista de Investigación Clínica},
publisher = {Permanyer},
url = {https://doi.org/10.24875/ric.21000028},
}
